✦ LIBER ✦

Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer

✍ Scribed by Thompson, A. M.

Book ID: 126777768
Publisher: American Association for Cancer Research
Year: 2014
Tongue: English
Weight: 599 KB
Volume: 20
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-13-0354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting FGFR with Dovitinib (TKI258):

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

✍ Andre, F.; Bachelot, T.; Campone, M.; Dalenc, F.; Perez-Garcia, J. M.; Hurvitz, 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 482 KB

Phase II clinical trials with rhizoxin i

Phase II clinical trials with rhizoxin in breast cancer and melanoma

✍ Hanauske, A-R; Catimel, G; Aamdal, S; ten Bokkel Huinink, W; Paridaens, R; Pavli 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 603 KB

Problems associated with randomized cont

Problems associated with randomized controlled clinical trials in breast cancer

✍ Ann E. Johnson FRCR; Consultant Surgical Oncologist 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

Variable selection in semiparametric cur

Variable selection in semiparametric cure models based on penalized likelihood, with application to breast cancer clinical trials

✍ Xiang Liu; Yingwei Peng; Dongsheng Tu; Hua Liang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

Controlled clinical trials with fenretin

Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia

✍ Giuseppe De Palo; Umberto Veronesi; Ettore Marubini; Tiziana Camerini; Fausto Ch 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 762 KB

We are conducting three randomized studies (breast cancer, basal cell carcinoma, oral leukoplakia) and report our methodological approach and accrual here. The aim of the breast cancer study is prevention of a contralateral primary lesion in women already treated for breast cancer; the aim of the b

Summary of aromatase inhibitor clinical

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

✍ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge